Search results
Story from Associated Retina Consultants: Local group helps macular degeneration patients cope with...
The Arizona Republic· 3 days ago“We find that it is very beneficial for people who are dealing with this disease to connect with...
Ontario sees more than 115 cases of eye damage after solar eclipse: What to do if you feel any pain
Yahoo Canada Style· 2 hours agoMoreover, it's easier to not feel the injury when it's occurring because the retina does not have...
American Society of Retina Specialists
Newswise· 4 days agoRetina specialists are board-certified ophthalmologists who have completed fellowship training in the medical and surgical treatment of retinal ...
Newswise Expert | Timothy G. Murray, American Society of Retina Specialists
Newswise· 4 days agoTimothy G. Murray, MD, MBA, is the President of the Foundation of the American Society of Retina Specialists (ASRS), the Immediate Past President of the ...
Astigmatism and Vision Correction: What to Know
AOL· 2 days agoIf you have astigmatism, your vision may be blurry and distorted instead of sharp and crisp. In astigmatism, the cornea (the clear dome that covers your eye) or the lens (which focuses light ...
Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment...
KTLA-TV Los Angeles· 4 days agoNanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced today the appointment of Allen ...
Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying - Lindblad...
Benzinga· 6 days agoTo acquire these shares, it cost around $10.49 million. What's Happening: On April 2, EyePoint...
AMD STOPPER Offers New Hope to Sufferers of Age-Related Macular Degeneration | Healthcare Dive
Healthcare Dive· 6 days agoAfter studying the cause and effects of AMD, he began self-experimenting with a new pharmaceutical formula in an attempt to save his central vision. Following several years of testing and reformulation ...
RevOpsis Secures $16.5 Million Seed Funding to Advance First-in-Class Tri-Specific Therapy for...
WPRI Providence· 4 days agoRevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today it has successfully closed its first seed funding round, raising ...
Solar panels in the eyes: reality or distant future?
CCM· 3 days agoImplanting tiny solar cells in people's eyes might sound like a futuristic idea, but it's what Australian scientists are exploring. This advanced...